With reference to news in www.moneycontrol.com dated August 23, 2017 quoting ‘Alkem Labs gets US FDA nod for rhinitis drug, Azelastine Hydrochloride Spray’. Alkem Laboratories has submitted a copy of clarification.
The above information is a part of company’s filings submitted to BSE.